These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 10871848

  • 1. p53-independent apoptosis associated with c-Myc-mediated block in myeloid cell differentiation.
    Amanullah A, Liebermann DA, Hoffman B.
    Oncogene; 2000 Jun 15; 19(26):2967-77. PubMed ID: 10871848
    [Abstract] [Full Text] [Related]

  • 2. Deregulated c-Myc prematurely recruits both Type I and II CD95/Fas apoptotic pathways associated with terminal myeloid differentiation.
    Amanullah A, Liebermann DA, Hoffman B.
    Oncogene; 2002 Feb 28; 21(10):1600-10. PubMed ID: 11896589
    [Abstract] [Full Text] [Related]

  • 3. Deregulated c-Myb expression in murine myeloid leukemias prevents the up-regulation of p15(INK4b) normally associated with differentiation.
    Schmidt M, Koller R, Haviernik P, Bies J, Maciag K, Wolff L.
    Oncogene; 2001 Sep 27; 20(43):6205-14. PubMed ID: 11593429
    [Abstract] [Full Text] [Related]

  • 4. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc.
    Haviernik P, Schmidt M, Hu X, Wolff L.
    Oncogene; 2003 Mar 20; 22(11):1600-10. PubMed ID: 12642863
    [Abstract] [Full Text] [Related]

  • 5. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.
    Eischen CM, Packham G, Nip J, Fee BE, Hiebert SW, Zambetti GP, Cleveland JL.
    Oncogene; 2001 Oct 25; 20(48):6983-93. PubMed ID: 11704823
    [Abstract] [Full Text] [Related]

  • 6. The proto-oncogene c-myc in hematopoietic development and leukemogenesis.
    Hoffman B, Amanullah A, Shafarenko M, Liebermann DA.
    Oncogene; 2002 May 13; 21(21):3414-21. PubMed ID: 12032779
    [Abstract] [Full Text] [Related]

  • 7. The c-Myc-interacting adaptor protein Bin1 activates a caspase-independent cell death program.
    Elliott K, Ge K, Du W, Prendergast GC.
    Oncogene; 2000 Sep 28; 19(41):4669-84. PubMed ID: 11032017
    [Abstract] [Full Text] [Related]

  • 8. Down-regulation of bcl-2 is associated with p16INK4-mediated apoptosis in non-small cell lung cancer cells.
    Kataoka M, Wiehle S, Spitz F, Schumacher G, Roth JA, Cristiano RJ.
    Oncogene; 2000 Mar 16; 19(12):1589-95. PubMed ID: 10734319
    [Abstract] [Full Text] [Related]

  • 9. p53 and p21waf-1 expression correlates with apoptosis or cell survival in poorly differentiated, but not well-differentiated, retinoblastomas.
    Divan A, Lawry J, Dunsmore IR, Parsons MA, Royds JA.
    Cancer Res; 2001 Apr 01; 61(7):3157-63. PubMed ID: 11306502
    [Abstract] [Full Text] [Related]

  • 10. Control of sensitivity to induction of apoptosis in myeloid leukemic cells by differentiation and bcl-2 dependent and independent pathways.
    Lotem J, Sachs L.
    Cell Growth Differ; 1994 Mar 01; 5(3):321-7. PubMed ID: 7517174
    [Abstract] [Full Text] [Related]

  • 11. Egr-1 abrogates the E2F-1 block in terminal myeloid differentiation and suppresses leukemia.
    Gibbs JD, Liebermann DA, Hoffman B.
    Oncogene; 2008 Jan 03; 27(1):98-106. PubMed ID: 17599039
    [Abstract] [Full Text] [Related]

  • 12. Inhibition by interleukin 4 of leukemia inhibitory factor-, interleukin 6-, and dexamethasone-induced differentiation of mouse myeloid leukemia cells: role of c-myc and junB proto-oncogenes.
    Kasukabe T, Okabe-Kado J, Hozumi M, Honma Y.
    Cancer Res; 1994 Jan 15; 54(2):592-7. PubMed ID: 8275499
    [Abstract] [Full Text] [Related]

  • 13. A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function.
    Kokontis JM, Wagner AJ, O'Leary M, Liao S, Hay N.
    Oncogene; 2001 Feb 08; 20(6):659-68. PubMed ID: 11313999
    [Abstract] [Full Text] [Related]

  • 14. The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells.
    Cartee L, Wang Z, Decker RH, Chellappan SP, Fusaro G, Hirsch KG, Sankala HM, Dent P, Grant S.
    Cancer Res; 2001 Mar 15; 61(6):2583-91. PubMed ID: 11289135
    [Abstract] [Full Text] [Related]

  • 15. Signaling through the antigen receptor of B lymphocytes activates a p53-independent pathway of c-Myc-induced apoptosis.
    Hagiyama H, Adachi T, Yoshida T, Nomura T, Miyasaka N, Honjo T, Tsubata T.
    Oncogene; 1999 Jul 15; 18(28):4091-8. PubMed ID: 10435590
    [Abstract] [Full Text] [Related]

  • 16. E2F activity is essential for survival of Myc-overexpressing human cancer cells.
    Santoni-Rugiu E, Duro D, Farkas T, Mathiasen IS, Jäättelä M, Bartek J, Lukas J.
    Oncogene; 2002 Sep 19; 21(42):6498-509. PubMed ID: 12226753
    [Abstract] [Full Text] [Related]

  • 17. Phosphatidylinositol 3-kinase/Akt signaling mediates interleukin-6 protection against p53-induced apoptosis in M1 myeloid leukemic cells.
    Vesely DL, Hoffman B, Liebermann DA.
    Oncogene; 2007 May 10; 26(21):3041-50. PubMed ID: 17099722
    [Abstract] [Full Text] [Related]

  • 18. Immediate early up-regulation of bax expression by p53 but not TGF beta 1: a paradigm for distinct apoptotic pathways.
    Selvakumaran M, Lin HK, Miyashita T, Wang HG, Krajewski S, Reed JC, Hoffman B, Liebermann D.
    Oncogene; 1994 Jun 10; 9(6):1791-8. PubMed ID: 8183578
    [Abstract] [Full Text] [Related]

  • 19. Myc down-regulation induces apoptosis in M14 melanoma cells by increasing p27(kip1) levels.
    D'Agnano I, Valentini A, Fornari C, Bucci B, Starace G, Felsani A, Citro G.
    Oncogene; 2001 May 17; 20(22):2814-25. PubMed ID: 11420693
    [Abstract] [Full Text] [Related]

  • 20. Characterization of the molecular mechanisms for p53-mediated differentiation.
    Chylicki K, Ehinger M, Svedberg H, Gullberg U.
    Cell Growth Differ; 2000 Nov 17; 11(11):561-71. PubMed ID: 11095245
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.